• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SURGICEL ABSORBABLE HEMOSTAT UNKNOWN; AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SURGICEL ABSORBABLE HEMOSTAT UNKNOWN; AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Paresis (1998); Foreign Body In Patient (2687); Convulsion/Seizure (4406)
Event Date 02/21/2022
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).H6.Component code: g07002 - device not returned.This report is related to a journal article, therefore no product will be returned for analysis and the manufacturing record evaluation cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number(s).Does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative patient consequences described in the article? does the surgeon believe there was any deficiency with the ethicon products used in this procedure? was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription steroids; antibiotics prescribed)? if so, please clarify.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Can specific patient demographics: initials; age or date of birth; bmi; gender; patient pre-existing medical conditions (i.E.Allergies, history of reactions), all concomitant medications, past medical history, any treatment required for events, dose, frequency, and therapy dates of study drugs be provided? citation: j neurosurg case lessons 2022;3(8): case21479.Doi: 10.3171/case21479.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported via a journal article: title: intracranial gossypiboma 9 years after intracranial pressure bolt insertion: illustrative case.Authors: ryan t.S.Loh, mbbchir,1 tomasz matys, md, phd, frcr,2 kieren s.J.Allinson, mbchb, frcpath, efn,3 and thomas santarius, md, phd, frcs(sn)4.Citation: j neurosurg case lessons 2022;3(8): case21479.Doi: 10.3171/case21479.The authors report a case of an intracranial gossypiboma, which is exceedingly rare and frequently radiologically indistinguishable from other lesions.A 35-year-old woman, who sustained a severe traumatic brain injury in a road traffic accident, underwent insertion of a triple-bolt monitoring device consisting of a licox brain tissue oxygenation probe (integra lifesciences), microdialysis catheter, and codman intraparenchymal icp probe (integra lifesciences), which is performed routinely in the authors' unit.Small superficial bleeding from the dura and brain surface during insertion was controlled with surgicel (ethicon).She did not undergo any other surgical interventions and subsequently made a full recovery.Reported complications include gossypiboma (n=1).In conclusion, the authors show that gossypibomas can occur following a relatively minor procedure and remain clinically and radiologically silent for much longer than previously reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURGICEL ABSORBABLE HEMOSTAT UNKNOWN
Type of Device
AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key16930215
MDR Text Key315214091
Report Number2210968-2023-03582
Device Sequence Number1
Product Code LMG
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
N12159
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 05/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/02/2023
Initial Date FDA Received05/15/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age35 YR
Patient SexFemale
-
-